Connecticut health officials have confirmed the first case of clade I mpox in the United States, marking a significant development in the ongoing global monitoring of the disease.

The patient had recently traveled to Western Europe before developing symptoms and testing positive for the more severe strain of mpox, according to state health authorities. Clade I mpox is considered more transmissible and potentially more severe than the clade II strain that has been circulating in the U.S. since 2022.

The confirmation comes as global health officials continue monitoring the spread of clade I mpox, which has been detected in several countries following outbreaks in Central Africa. The World Health Organization has been tracking the emergence of this strain outside of Africa with particular attention.

Health authorities have not released additional details about the patient's condition or specific travel history. Connecticut health officials are conducting contact tracing and monitoring individuals who may have been exposed to the patient.

The case represents the first detection of clade I mpox in the United States, though other countries including the United Kingdom and several European nations have reported cases in recent months. Public health experts emphasize that the risk to the general population remains low, but the detection highlights the importance of continued surveillance for emerging infectious diseases.